Home oxygen therapy as model of Medicare cost-control touted by Apria's Rapp.
This article was originally published in The Gray Sheet
HOME OXYGEN THERAPY AS MEDICARE COST-CONTROL MODEL touted by Richard Rapp, senior VP of Apria Healthcare, at a House Ways and Means/Health Subcommittee hearing July 25 on Medicare reform. "The current structure of reimbursement of home oxygen services offers a model for utilization and cost controls that can be applied to other parts of Medicare" currently served on a fee reimbursement basis, Rapp said.
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.